U.S. drug prices hit by insurer tactic against copay assistance: analysis

NEW YORK (Reuters) - A recently adopted tactic by U.S. health plans to limit the financial assistance drugmakers provide directly to consumers for prescription medicines is taking a toll on drug prices, according to a new analysis released on Tuesday.

from Reuters: U.S. https://ift.tt/2HooNrf